Psoriatic arthritis

F1000Res. 2019 Sep 20;8:F1000 Faculty Rev-1665. doi: 10.12688/f1000research.19144.1. eCollection 2019.

Abstract

Psoriasis is a multisystemic, inflammatory skin condition that can affect many areas of the body, but most commonly the extensor surfaces of the elbows and knees, and sometimes the intergluteal and umbilical area. It has a prevalence of 2-4% in western adults, and 20--30% of psoriasis patients will develop psoriatic arthritis (PsA). PsA is an inflammatory musculoskeletal disease associated with cutaneous psoriasis. It affects men and women almost equally with a peak age at onset of 40 and 50 years. It is a diverse disease that affects multiple organ systems includes peripheral and axial joints, entheses, skin, and nails. PsA is associated with comorbidities such as osteoporosis, uveitis, subclinical bowel inflammation, and cardiovascular disease. Given this heterogeneity, its diagnosis has been difficult. Here we present an updated review of its classification criteria CASPAR (classification criteria for PsA), use of screening tools to aid in early diagnosis, recent findings on pathogenesis, and new therapeutic approaches including new biologic medications.

Keywords: biomarkers; pathogenesis; psoriatic arthritis; treatment.

Publication types

  • Review

MeSH terms

  • Arthritis, Psoriatic / diagnosis*
  • Arthritis, Psoriatic / pathology
  • Arthritis, Psoriatic / therapy*
  • Comorbidity
  • Humans
  • Skin / pathology

Grant support

The author(s) declared that no grants were involved in supporting this work.